Q fever, a zoonotic disease caused by the bacterium Coxiella Burnetii, presents a significant public health concern globally. It can cause serious illness in humans, making prevention and control measures crucial, especially in high-risk occupational settings.
Vaccination plays a pivotal role in preventing Q fever, particularly among high-risk occupational groups such as abattoir workers, farmers, and veterinary professionals. Immunization helps reduce the incidence of the disease, protecting individuals and communities from its potentially severe consequences.
Prior to vaccination, individuals should undergo pre-vaccination testing, including serological and skin tests, to assess their immune status and ensure vaccine suitability. Contraindications and precautions should be discussed with Employees Health healthcare professionals to determine if individuals are suitable candidates for vaccination.
Burnetii, an obligate intracellular bacterium, primarily infects animals like cattle, sheep, and goats. Humans typically acquire the infection through inhalation of contaminated aerosols or dust. The disease can manifest as acute or chronic, with symptoms ranging from flu-like illness to severe complications such as endocarditis.
Q fever is a notifiable disease in many countries, including Australia, where it poses a particular concern due to its impact on occupational health. By highlighting the epidemiology of Q fever and the effectiveness of vaccination initiatives, Employees Health aims to support public health efforts in controlling and preventing the spread of the disease.
Employees Health Medical Corporate Provider offers a range of corporate health services nationwide, aimed at ensuring the well-being of employees across various industries. Our comprehensive approach includes:
Employees Health is committed to providing educational resources to enhance understanding of Q fever and vaccination protocols. We offer:
By leveraging these resources, Employees Health ensures that individuals and organisations are well- informed and equipped to handle the risks associated with Q fever, promoting a healthier and safer workplace environment nationwide
The Australian Immunisation Handbook recommends that people aged 15 years and over at risk of Q fever have both a blood antibody test and a skin test before vaccination. The skin test is read after 7 days, and the vaccine is given only if both results are negative. It is a single dose and boosters are not recommended.
The Handbook recommends vaccination for people at risk of infection, including abattoir and stockyard workers, farmers, shearers, animal transporters, veterinary staff and students, wildlife and zoo workers, pet food manufacturers and some laboratory workers. People with previous Q fever infection or vaccination should not be vaccinated.
WHS regulators treat Q fever vaccination as a key control. Safe Work Australia says employers should give at-risk workers access to vaccination, and SafeWork NSW and WorkSafe Victoria guidance says non-immune workers should be kept out of high-risk areas or given other protection. Whether vaccination can be a condition of a particular job depends on the circumstances, so employers should seek advice for their situation.
The vaccine is highly effective, but no vaccine gives complete protection. Studies cited in the Handbook found most vaccinated people developed immunity lasting at least 5 years. Vaccinated workers should still follow hygiene, PPE and animal-handling controls.
Yes. Employees Health can provide pre-vaccination screening and vaccination onsite at abattoirs, farms, veterinary practices and other high-risk workplaces, anywhere in Australia. Because the skin test must be read 7 days later, sessions are planned as two visits.
